Ozempic, will wegovy will be cheaper in the near future?
Can the high cost of high -popular weight loss drugs are available in the near future?
Cheddar
Many Americans have made pharmacies complex to obtain popular weight loss drugs due to lack of availability or expensive retail tags. But this option will soon be closed to consumers.
The federal government allows pharmacies to sell copies of drugs when drugs are insufficient. However, the federal regulators recently declared that the blockbuster weight loss drugs were no longer lacking. In other words, consumers who use remote healthy companies or medical spas must obtain a cheap and complex version to get drugs elsewhere.
It was embarrassed by consumers such as Amanda Bonello, three mothers, who were forced to buy a brand version of the drug that she could not afford. She sells the drug of Eli Lilly, a complex version of DIRZEPATIDE under the name Mounjaro, treats diabetes and brings Zepbound to lose weight. The average sleeve price of Zepbound is Almost $ 1,300According to GOODRX, a prescription discount provider.
Bonello said, “I leave the stream without paddles.” “We all feel like we are on the island, Big Pharma has the only source of food, and all unavoidable people can starve to die.”
Industry groups representing complex pharmacies and suppliers have sued to continue to sell these drugs. And patients started Online petition To extend the time to use the combined GLP -1 or glucagon -like peptide -1. Or petitions are recommended for food pharmacies to approve generic versions or lower retail prices for pharmaceuticals. This petition also intends to force health insurance companies to guarantee these drugs.
What is the state of complex Wegovy and Zepbound?
Complex suppliers and pharmacies can no longer create and sell weight loss drugs for the mass market. The federal government has already approved partially closed conversion periods for the complex versions of Zepbound and Mounjaro. Consumers will take a little longer to get a composite semagluide sold by the brand WEGOVY and Ozempic for Diabetes to lose weight.
In December, the FDA declared that Ellie Lily’s Tirje Fade was no longer supplying. The FDA stopped the Tour’s fetide by February 18 to stop the complex, distribution or distribution by February 18. Suppliers that produce drug layouts and sell to others March 19th Stop the distribution. The Industry Trade Group Outsourcing Facility Association has submitted the Texas US District Court to accuse the FDA and delay such execution.
The FDA urged the court to reject the group’s request in legal response to the trade group’s consent. The agency insisted that the request would “maximize patient safety” and complied with the intentions of Congress to encourage the development of parliamentary drugs while allowing complexes during temporary drugs.
Last month, the FDA said Novo Nordisk’s lack of Semaglutide was over. Pharmacies should stop selling complex details by April 22. Facilities that supply complex semi -glue tide should stop drug distribution by May 22.
Take a composite weight loss drug. What will my doctor or pharmacist tell me?
Pharmacists who supply complex weight loss and diabetes drugs are already discussing situations with customers. Some do not refill prescriptions. Others do not want to start new customers as a complex drug because others have to switch to brand medicines.
Within a year of stopping Semaglutide, 327 patient groups in the United States, Europe and Japan have recovered two -thirds of their weight while receiving drug treatment. study Established The study also said that patients were less healthy than drug treatment.
Jennifer Burch, who runs an independent complex pharmacy in North Carolina, tells all the patients about how complex drugs can be used only when the brand name is in the FDA’s shortage list.
She dominates the questions of those who are interested in starting a complex TPAID. At the end of drug shortages, she advises the patient not to start taking complex drugs if he cannot access or handle brand drugs.
“We try to inform it earlier,” said Burch, chairman of the Pharmacy Compounding Foundation. “We don’t want to take out the rugs under the rug.”
BURCH wants some patients to reserve complex drugs for up to one year because they want a doctor to write long -term prescriptions. But doctors are reluctant to do so because they have to monitor the weight loss and overall health of the patient during drug treatment, she said.
“The provider said yesterday.
CEO Scott Brunner is a pharmacy complex industry association (IS
Brunner said the patient often should go back to doctors and remote health providers and get a new prescription for weight loss drugs. This conversion period provides enough time to prepare for change without a sudden change of patient prescription to the pharmacy.
“This is about the sustainability of treatment, and it is to prevent the patient from experiencing the interruption of treatment.” “Suddenly ending these GLP-1 drugs can lead to health potential results.”
What are you doing to make the brand version of weight loss drugs cheaper?
Most large companies that provide health insurance benefits to workers and private insurance companies deal with diabetes drugs such as Ozempic and Mounjaro.
However, last year, a survey by a benefit consultant Mercer found that half of the large-scale employers applied GLP-1 drugs to obesity. This means that consumers often face a large fee for drugs sold for about $ 1,300 a month before rebates or discounts.
Congress closely investigated the pharmaceutical company on the retail price of these drugs, while the pharmaceutical company launched a discounted direct consumer option.
Ellie Lily last week I slashed the monthly price In the case of consumers who pay cash through pharmaceutical companies, in the case of ZEPBOUND, Lily Director Website. Consumers who purchase a monthly supply of 2.5mg vials now Pay $ 349 and the 5mg vial is $ 499. Lilly also announced a higher dose of 7.5 and 10 mg at $ 599 and $ 699 per month. These high doses prices are $ 499 per month for the first filling, and you will receive a refilled refill within 45 days.
Meanwhile, drug complexes are still pressing the legal issue of the FDA’s decision to declare a lack of weight loss. The Outsourcing Facility Association sued the FDA for the decision to declare WEGOVY and Ozempic of Novo Nordisk on Monday. The industry has previously sued the agency for the declaration that LILLY’s Tirzepatide was no longer supplying.
In the Tirzepatide lawsuit, OFA raised the consent of claiming that the FDA’s shortage decision was a new rules that required more comprehensive regulatory processes. The federal judge has not yet made a ruling. The FDA said that the court will not implement the closing date of about February 18, which will be welfare for the pharmacy to stop the pharmacy until the court defines the rules for consent.
After the FDA proclaimed the Tyr disciple’s shortage, Bonelo asked the doctor to convert to a composite semi -glue tide. Now she knows that it is not a continuous solution.
Her job insurance plan deals with GLP-1 diabetes drugs, but does not deal with weight loss pharmaceuticals. She has a high blood sugar, but she doesn’t have diabetes despite her diagnosis.
Bonello said, despite Lilly’s discounted $ 499 for the higher doses published this week, she said she could not afford the amount and still pay everyday life.
“This is more than the combination of my phone bill and auto insurance,” she said.
